IRIS
SULLI, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 27.666
Totale 27.666
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 27.666
Totale 27.666
Salva come PNG Salva come JPEG
Città #
Genova 20.574
Genoa 2.722
Rapallo 2.704
Vado Ligure 1.575
Bordighera 91
Totale 27.666
Salva come PNG Salva come JPEG
Nome #
Nailfold capillaroscopy for day-to-day clinical use: construction of a simple scoring modality as a clinical prognostic index for digital trophic lesions. 514
Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts 162
Vitamin D deficiency and clinical correlations in systemic sclerosis patients: A retrospective analysis for possible future developments. 152
Effects of CTLA4-Ig treatment on circulating fibrocytes and skin fibroblasts from the same systemic sclerosis patients: an in vitro assay 146
Altered circadian rhythms in rheumatoid arthritis patients play a role in the disease's symptoms. 142
Increase in circulating cells coexpressing M1 and M2 macrophage surface markers in patients with systemic sclerosis 142
Correction: Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages 137
Anti-inflammatory effects of leflunomide on cultured synovial macrophages from patients with rheumatoid arthritis. 136
CTLA4-Ig interacts with cultured synovial macrophages from rheumatoid arthritis patients and downregulates cytokine production. 135
A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement. 135
Correlation between circulating fibrocytes and dermal thickness in limited cutaneous systemic sclerosis patients: a pilot study 134
Cross-cultural adaptation and validity of the Italian version of the Central Sensitization Inventory 133
The hypothalamic-pituitary-adrenocortical and gonadal axis function in rheumatoid arthritis. 131
Atlas of Capillaroscopy in Rheumatic Diseases 131
Nailfold Capillaroscopy and Clinical Applications in Systemic Sclerosis 131
European multicentre pilot survey to assess vitamin D status in rheumatoid arthritis patients and early development of a new Patient Reported Outcome questionnaire (D-PRO). 131
[CTLA4-Ig interferes and downregulates the proinflammatory activities of rheumatoid synovial macrophages in monoculture] 129
Cyclosporin A and iloprost treatment of systemic sclerosis: clinical results and interleukin-6 serum changes after 12 months of therapy. 128
Pregnancy, cytokines and disease activity in systemic lupus erythematosus 128
Timing of transition between capillaroscopic patterns in systemic sclerosis. 127
Modulation of cell growth and apoptosis by sex hormones in cultured monocytic THP-1 cells. 127
Blunted coronary flow reserve in systemic sclerosis: a sign of cardiac involvement in asymptomatic patients 126
Androgen and estrogen receptors are present in primary cultures of human synovial macrophages. 125
Therapy. Optimized treatment algorithms for digital vasculopathy in SSc. 125
Quantitative Alterations of Capillary Diameter Have a Predictive Value for Development of the Capillaroscopic Systemic Sclerosis Pattern 125
Vitamin D endocrine system involvement in autoimmune rheumatic diseases 124
Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis. 123
Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study. 123
Air Travel, Circadian Rhythms/Hormones, and Autoimmunity. 123
Nocturnal hormones and clinical rhythms in rheumatoid arthritis. 122
Stabilization of Microcirculation in Patients with Early Systemic Sclerosis with Diffuse Skin Involvement following Rituximab Treatment: An Open-label Study 122
Estrogens interfere with leflunomide modulation of cytokine production by human activated monocytes. 122
Subclinical dermal involvement is detectable by high frequency ultrasound even in patients with limited cutaneous systemic sclerosis. 121
Alternatively Activated (M2) Macrophage Phenotype Is Inducible by Endothelin-1 in Cultured Human Macrophages. 121
Effects of combined treatments with CTLA4-IG (abatacept), dexamethasone and methotrexate on cultured human macrophages 120
Systemic sclerosis: state of the art on clinical practice guidelines 120
Serum cytokines and steroidal hormones in polymyalgia rheumatica and elderly-onset rheumatoid arthritis 119
Estrogen's effects in chronic autoimmune/inflammatory diseases and progression to cancer 118
Estrogens interfere with leflunomide modulation of cytokine production by human activated monocytes. 117
Correlations between blood perfusion and dermal thickness in different skin areas of systemic sclerosis patients 116
Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosis. 115
Scoring the nailfold microvascular changes during the capillaroscopic analysis in systemic sclerosis patients 114
Effects of estrogens on extracellular matrix synthesis in cultures of human normal and scleroderma skin fibroblasts. 113
Androgen metabolism and inhibition of interleukin-1 synthesis in primary cultured human synovial macrophages. 113
Relations between steroid hormones and cytokines in rheumatoid arthritis and systemic lupus erythematosus. 113
Quantitative outcome measures for systemic sclerosis-related Microangiopathy - Reliability of image acquisition in Nailfold Capillaroscopy. 113
An international SUrvey on non-iNvaSive tecHniques to assess the mIcrocirculation in patients with RayNaud's phEnomenon (SUNSHINE survey). 113
Correlations between nailfold microvascular damage and skin involvement in systemic sclerosis patients. 113
Aminaphtone Efficacy in Primary and Secondary Raynaud's Phenomenon: A Feasibility Study 113
Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison. 112
Validity of the rheumatoid arthritis impact of disease (RAID) score and definition of cut-off points for disease activity states in a population-based European cohort of patients with rheumatoid arthritis 112
Effects of Longterm Treatment with Bosentan and Iloprost on Nailfold Absolute Capillary Number, Fingertip Blood Perfusion, and Clinical Status in Systemic Sclerosis. 112
Short-term follow-up of digital ulcers by laser speckle contrast analysis in systemic sclerosis patients 111
Evidence of cerebral hypoperfusion in scleroderma patients. 111
Brachial Artery Endothelial-dependent Flow-mediated Dilation Identifies Early-stage Endothelial Dysfunction in Systemic Sclerosis and Correlates with Nailfold Microvascular Impairment 111
Automated assessment of absolute nailfold capillary number on videocapillaroscopic images: Proof of principle and validation in systemic sclerosis 111
Estrogens, autoimmunity and the heart. 111
Anti-inflammatory effects of leflunomide in combination with methotrexate on co-culture of T lymphocytes and synovial macrophages from rheumatoid arthritis patients. 111
Ehlers-Danlos syndromes: state of the art on clinical practice guidelines. 111
Primary cultures of human synovial macrophages metabolize androgens. 110
An EULAR study group pilot study on reliability of simple capillaroscopic definitions to describe capillary morphology in rheumatic diseases 110
Innovations in the Assessment of Primary and Secondary Raynaud's Phenomenon 110
Longterm treatment with endothelin receptor antagonist bosentan and iloprost improves fingertip blood perfusion in systemic sclerosis. 109
Correlations between nailfold microangiopathy severity, finger dermal thickness and fingertip blood perfusion in systemic sclerosis patients 109
Correlations between skin blood perfusion values and nailfold capillaroscopy scores in systemic sclerosis patients 108
Long-term follow-up of nailfold videocapillaroscopic changes in dermatomyositis versus systemic sclerosis patients 108
Polymyalgia rheumatica vs late-onset rheumatoid arthritis. 107
Vitamin D, steroid hormones, and autoimmunity. 107
Effects of macitentan and its active metabolite on cultured human systemic sclerosis and control skin fibroblasts 107
CTLA-4 blockade in the treatment of rheumatoid arthritis: an update 107
Role of estrogens in inflammatory response: expression of estrogen receptors in peritoneal fluid macrophages from endometriosis 107
Cortisol, dehydroepiandrosterone sulfate, and androstenedione levels in patients with polymyalgia rheumatica during twelve months of glucocorticoid therapy. 106
Assessment of treatment effects on digital ulcer and blood perfusion by laser speckle contrast analysis in a patient affected by systemic sclerosis 106
Progression of Organ Involvement in Systemic Sclerosis Patients with Persistent "Late" Nailfold Capillaroscopic Pattern of Microangiopathy: A Prospective Study. 106
Glucocorticoid effects on adrenal steroids and cytokine responsiveness in polymyalgia rheumatica and elderly onset rheumatoid arthritis. 106
null 105
[Physiopathology and biomechanics of hip osteoarthritis] 104
Brain functional involvement by perfusion SPECT in Systemic Sclerosis and Behcet’s disease. 104
Androgen status in postmenopausal patients with rheumatoid arthritis. 103
Circadian use of glucocorticoids in rheumatoid arthritis 103
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study. 103
Anti-inflammatory mechanisms of methotrexate in rheumatoid arthritis. 103
Impaired quantitative cerebral blood flow in scleroderma patients. 102
Identification of transition from primary Raynaud's phenomenon to secondary Raynaud's phenomenon by nailfold videocapillaroscopy: comment on the article by Hirschl et al. 102
Methods for the morphological and functional evaluation of microvascular damage in systemic sclerosis 102
Assessing microvascular changes in systemic sclerosis diagnosis and management. 102
Adrenal gland hypofunction in active polymyalgia rheumatica. effect of glucocorticoid treatment on adrenal hormones and interleukin 6. 101
Macroamylasemia: a possible cause of unexplained hyperamylasemia in rheumatoid arthritis. 101
Endothelin receptor antagonists: effects on extracellular matrix synthesis in primary cultures of skin fibroblasts from systemic sclerosis patients. 101
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study. 101
Synovial fluid estrogens in rheumatoid arthritis. 101
Laser speckle contrast analysis: a new method to evaluate peripheral blood perfusion in systemic sclerosis patients 101
Circadian rhythms: glucocorticoids and arthritis. 101
Inflammatory gene profile in early rheumatoid arthritis and modulation by leflunomide and prednisone treatment. 100
Estrogen metabolism and autoimmunity. 100
The contribution of capillaroscopy to the differential diagnosis of connective autoimmune diseases. 99
Evaluation of blood perfusion by laser speckle contrast analysis in different areas of hands and face in patients with systemic sclerosis 99
NF-KB involvement for CTLA4-IG intracellular signaling in human macrophages 99
Prospective capillaroscopy-based study on transition from primary to secondary Raynaud's phenomenon: preliminary results. 98
Anti-TNF and sex hormones 98
Totale 11.932
Salva come PNG Salva come JPEG
Categoria #
all - tutte 85.208
article - articoli 78.377
book - libri 0
conference - conferenze 4.218
curatela - curatele 243
other - altro 137
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.233
Totale 170.416
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20206.550 0 0 0 0 694 779 1.084 585 777 1.392 915 324
2020/20212.316 122 180 459 134 169 184 118 172 237 219 165 157
2021/20223.719 99 258 314 379 106 196 317 883 201 360 160 446
2022/20233.265 359 166 29 280 574 513 23 309 546 25 405 36
2023/20242.138 97 307 32 213 160 359 139 210 92 39 114 376
2024/20251.789 285 491 202 422 389 0 0 0 0 0 0 0
Totale 28.431